Column
You can view the research column published every month by SMC Laboratories.
2024.04.08
【Hot data】 Resmetirom (MGL-3196) evaluation data available in STAMTM model
MASH
Resmetirom
STAM
As you may already know, the United States Food and Drug Administration (FDA) announced the approval of Rezdiffra (resmetirom), developed by Madrigal Pharmaceuticals, as the first treatment for MASH. If you are developing a MASH treatment in this situation, you have the possibility to utilize the STAM™-HCC/IO+ model and get the most out of…
READ MORE
